Reactivation of latent viral hepatitis infection in patients of chronic myeloid leukemia treated with imatinib mesylate: Experience from a tertiary cancer center in India.

被引：0
|
作者：
Ostwal, V. [1 ]
Ghadyalpatil, N. [1 ]
Prabhash, K. [1 ]
Menon, H. [1 ]
Nair, R. [1 ]
Sengar, M. [1 ]
Noronha, V. [1 ]
Biswas, S. [1 ]
Bhosale, B. [1 ]
Banavali, S. [1 ]
机构：
[1] Tata Mem Hosp, Bombay 400012, Maharashtra, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6593
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6593
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Renal phosphate loss in Iraqi chronic myeloid leukemia patients treated by imatinib mesylate
    Al-Taee, Huda A.
    Athab, Azhar K.
    Ali, Ala
    IRAQI JOURNAL OF HEMATOLOGY, 2020, 9 (02) : 72 - 76
  • [22] Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate
    C Schoch
    T Haferlach
    W Kern
    S Schnittger
    U Berger
    R Hehlmann
    W Hiddemann
    A Hochhaus
    Leukemia, 2003, 17 : 461 - 463
  • [23] Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate
    Schoch, C
    Haferlach, T
    Kern, W
    Schnittger, S
    Berger, U
    Hehlmann, R
    Hiddemann, W
    Hochhaus, A
    LEUKEMIA, 2003, 17 (02) : 461 - 463
  • [24] IMATINIB MESYLATE IN THE TREATMENT OF PAEDIATRIC CHRONIC MYELOID LEUKEMIA: A STUDY OF 55 PATIENTS FROM A TERTIARY CARE CANCER CENTRE IN PAKISTAN
    Rashid, Aqeela
    Maaz, Ata
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1038 - 1038
  • [25] Multicenter experience with imatinib, mesylate in newly diagnosed chronic myeloid leukemia (CML) patients
    Carella, A. M.
    Lerma, E.
    Orlandi, E.
    Lazzarino, M.
    Annunziata, M.
    Ferrara, F.
    Pungolino, E.
    Morra, E.
    Miglino, M.
    Gobbi, M.
    BLOOD, 2007, 110 (11) : 210B - 210B
  • [26] Imatinib mesylate in chronic myeloid leukemia (CML): A single institution experience of 174 patients
    Deshmukh, CD
    Saikia, T
    Bakshi, AV
    Parikh, PM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 610S - 610S
  • [27] Imatinib in pediatric chronic myeloid leukemia patients - An India experience.
    Suresh, Attili
    Appaji, L.
    Bapsy, P. P.
    Kumari, B. S. Aruna
    Govindbabu, K.
    Lokanatha, Dasappa
    Anupama, G.
    Suresh, Attili
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 466 - 466
  • [28] Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country
    Rajappa, Senthil
    Varadpande, Lalit
    Paul, Tara
    Jacob, Rachel
    Digumarti, Raghunadharao
    LEUKEMIA & LYMPHOMA, 2008, 49 (03) : 554 - 558
  • [29] Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country
    Medhi, Kunjahari
    Raina, Vinod
    Kumar, Lalit
    Sharma, Atul
    Bakhshi, Sameer
    Gupta, Ritu
    Kumar, Rajive
    LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1850 - 1854
  • [30] Incidence of imatinib resistance in chronic myeloid leukemia (CML) patients: Experience from resource poor center of eastern India
    Bhattacharyya, D.
    Ghosh, R.
    Gupta, P.
    Gupta, A.
    Roychoudhury, S.
    Nath, S.
    ANNALS OF ONCOLOGY, 2019, 30
12345